Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 1
1917 1
1925 1
1932 1
1962 1
1969 1
1970 5
1971 2
1972 2
1973 1
1974 5
1975 1
1976 1
1982 2
1983 2
1984 9
1985 3
1986 1
1987 9
1988 5
1989 3
1990 1
1991 1
1992 1
1993 1
1994 1
1995 2
1996 5
1997 2
1998 2
1999 3
2000 3
2001 2
2002 2
2003 10
2004 11
2005 5
2006 4
2007 9
2008 5
2009 10
2010 11
2011 26
2012 24
2013 26
2014 19
2015 23
2016 24
2017 35
2018 38
2019 36
2020 45
2021 62
2022 53
Text availability
Article attribute
Article type
Publication date

Search Results

513 results
Results by year
Filters applied: . Clear all
Page 1
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
Perera D, Clayton T, O'Kane PD, Greenwood JP, Weerackody R, Ryan M, Morgan HP, Dodd M, Evans R, Canter R, Arnold S, Dixon LJ, Edwards RJ, De Silva K, Spratt JC, Conway D, Cotton J, McEntegart M, Chiribiri A, Saramago P, Gershlick A, Shah AM, Clark AL, Petrie MC; REVIVED-BCIS2 Investigators. Perera D, et al. N Engl J Med. 2022 Oct 13;387(15):1351-1360. doi: 10.1056/NEJMoa2206606. Epub 2022 Aug 27. N Engl J Med. 2022. PMID: 36027563 Clinical Trial.
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Solomon T, et al. Among authors: perera d. Lancet Infect Dis. 2010 Nov;10(11):778-90. doi: 10.1016/S1473-3099(10)70194-8. Epub 2010 Oct 18. Lancet Infect Dis. 2010. PMID: 20961813 Review.
Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for Ischemic Cardiomyopathy.
Perera D, Clayton T, Petrie MC, Greenwood JP, O'Kane PD, Evans R, Sculpher M, Mcdonagh T, Gershlick A, de Belder M, Redwood S, Carr-White G, Marber M; REVIVED investigators. Perera D, et al. JACC Heart Fail. 2018 Jun;6(6):517-526. doi: 10.1016/j.jchf.2018.01.024. JACC Heart Fail. 2018. PMID: 29852933 Free article.
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.
Vantaku V, Dong J, Ambati CR, Perera D, Donepudi SR, Amara CS, Putluri V, Ravi SS, Robertson MJ, Piyarathna DWB, Villanueva M, von Rundstedt FC, Karanam B, Ballester LY, Terris MK, Bollag RJ, Lerner SP, Apolo AB, Villanueva H, Lee M, Sikora AG, Lotan Y, Sreekumar A, Coarfa C, Putluri N. Vantaku V, et al. Among authors: perera d. Clin Cancer Res. 2019 Jun 15;25(12):3689-3701. doi: 10.1158/1078-0432.CCR-18-1515. Epub 2019 Mar 7. Clin Cancer Res. 2019. PMID: 30846479 Free PMC article.
Multi-omic Profiling Reveals Dynamics of the Phased Progression of Pluripotency.
Yang P, Humphrey SJ, Cinghu S, Pathania R, Oldfield AJ, Kumar D, Perera D, Yang JYH, James DE, Mann M, Jothi R. Yang P, et al. Among authors: perera d. Cell Syst. 2019 May 22;8(5):427-445.e10. doi: 10.1016/j.cels.2019.03.012. Epub 2019 May 8. Cell Syst. 2019. PMID: 31078527 Free PMC article.
Cardiac-Coronary Coupling.
Perera D. Perera D. J Am Coll Cardiol. 2016 Oct 11;68(15):1661-1663. doi: 10.1016/j.jacc.2016.07.752. J Am Coll Cardiol. 2016. PMID: 27712779 Free article. No abstract available.
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
Mill CP, Fiskus W, DiNardo CD, Qian Y, Raina K, Rajapakshe K, Perera D, Coarfa C, Kadia TM, Khoury JD, Saenz DT, Saenz DN, Illendula A, Takahashi K, Kornblau SM, Green MR, Futreal AP, Bushweller JH, Crews CM, Bhalla KN. Mill CP, et al. Among authors: perera d. Blood. 2019 Jul 4;134(1):59-73. doi: 10.1182/blood.2018893982. Epub 2019 Apr 25. Blood. 2019. PMID: 31023702 Free PMC article.
513 results